US FDA approves Merck's new injectable version of Keytruda
1. FDA approves Keytruda's new under-the-skin formulation for easier administration.
FAQ
Why Bullish?
The FDA approval may increase Keytruda's uptake, enhancing revenue potential for Merck.
How important is it?
The convenience of the new formulation is likely to attract more patients and providers.
Why Long Term?
Increased patient access can lead to sustained revenue growth over several years.